Hypertensive retinopathy as the first manifestation of extra-adrenal paraganglioma.
Karagiannidou Z, Bontzos G, Plaka A, Makrygiannis G.
Hormones (Athens). 2025 May 28. doi: 10.1007/s42000-025-00675-x. Online ahead of print.
von Hippel-Lindau syndrome.
Chou A, Toon C, Pickett J, Gill AJ.
Front Horm Res. 2013;41:30-49. doi: 10.1159/000345668. Epub 2013 Mar 19.
Phaeochromocytoma.
Foo M, Burton BJ, Ahmed R.
Br J Hosp Med. 1995 Oct 4-17;54(7):318-21.
von Hippel-Lindau disease.
Couch V, Lindor NM, Karnes PS, Michels VV.
Mayo Clin Proc. 2000 Mar;75(3):265-72. doi: 10.4065/75.3.265.
Hypertensive retinopathy associated with adrenal medullary tumor (pheochromocytoma).
RODIN FH.
Arch Ophthal. 1945 Nov-Dec;34:402-7. doi: 10.1001/archopht.1945.00890190404009.
Hypertensive retinopathy.
Brandenburg VM, Schrage N.
Wien Klin Wochenschr. 2005 Mar;117(5-6):187. doi: 10.1007/s00508-005-0325-z.
Genetics in neuro-oncology.
Martuza RL.
Clin Neurosurg. 1983;31:417-40. doi: 10.1093/neurosurgery/31.cn_suppl_1.417.
[Hippel-Lindau disease].
Krzystolik K, Cybulski C, Lubiński J.
Neurol Neurochir Pol. 1998 Sep-Oct;32(5):1119-33.
Catecholamine-secreting tumours.
Sandler M.
Proc R Soc Med. 1967 Aug;60(8):795-7. doi: 10.1177/003591576706000842.
Hippel-Lindau syndrome.
Coulam CM, Brown LR, Reese DF.
Semin Roentgenol. 1976 Jan;11(1):61-6. doi: 10.1016/0037-198x(76)90064-x.
